ClinicalTrials.gg
Sign In

Biological

Tyrosinase Peptide clinical trials

studies test it
4
open now
0
in phase 3
1
first study started
1999

How studies write it

Studies that test it under each name

Name

tyrosinase peptide
4

Studies by the year they started

4 studies that test it; most in 1999 (2)

Studies that test Tyrosinase Peptide, by start year
YearStudies
19992
20001
20031

By phase

A phase 1/2 study counts in both.

Phase 1
1
Phase 2
2
Phase 3
1

What it is tested for

Each study’s main condition, where its own words name it.

Melanoma
3
Uveal Melanoma
1

Who runs them

Industry 0 · Other 4

National Cancer Institute (NCI) (2) · University of Southern California (2)

Often tested with

Tested in the same studies.

MART-1 Antigen (2) · GP-100 antigen (2) · Sargramostim (1) · gp100:209-217(210M) Peptide Vaccine (1) · Dendritic Cell-MART-1 Peptide Vaccine (1) · Therapeutic Tumor Infiltrating Lymphocytes (1) · Recombinant CD40-Ligand (1)

Studies

Open first, then newest update. How each study uses Tyrosinase Peptide is read from its arms, and is right about nine times in ten.

Testing it · 4

Given in every arm · 4 — Tyrosinase Peptide is usual care beside what is tested